Balance Sheet - Structure Therapeutics Inc. (GPCR)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | |
|---|---|---|---|---|---|---|
| Total cash and short-term investments | 1,446.20 | 883.52 | 467.32 | 90.84 | 107.31 | 37.45 |
| Other current assets | 124.11 | 7.69 | 6.29 | 2.25 | 1.94 | 0.97 |
| Total current assets | 1,570.30 | 891.21 | 473.61 | 93.09 | 109.25 | 38.42 |
| Total non-current assets | 13.62 | 12.12 | 8.41 | 4.76 | 1.91 | 0.29 |
| Total assets | 1,583.92 | 903.33 | 482.02 | 97.85 | 111.16 | 38.70 |
| Total current liabilities | 63.29 | 36.02 | 24.74 | 13.01 | 8.66 | 3.04 |
| Total non-current liabilities | 4.26 | 2.47 | 4.31 | 199.98 | 167.23 | 58.13 |
| Total liabilities | 67.54 | 38.49 | 29.05 | 212.99 | 175.89 | 61.17 |
| Total stockholders' equity | 1,516.38 | 864.84 | 452.97 | -115.14 | -64.74 | -22.47 |
| Common shares outstanding | 59 | 53 | 37 | 37 | 37 | 37 |
Show Quarterly Balance Sheet
Balance Sheet - Structure Therapeutics Inc. (GPCR)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 1,458.50 | 1,446.20 | 799.04 | 786.50 | 836.88 | 883.52 | 915.29 | 927.12 | 436.45 | 467.32 | 205.42 | 224.59 | 240.86 | 90.84 | 102.75 | 0.00 | 107.31 | 107.31 |
| Other current assets | 32.09 | 124.11 | 14.98 | 12.80 | 12.74 | 7.69 | 8.37 | 10.50 | 12.91 | 6.29 | 4.54 | 3.64 | 5.29 | 2.25 | 2.02 | 1.94 | ||
| Total current assets | 1,490.60 | 1,570.30 | 814.02 | 799.30 | 849.62 | 891.21 | 923.65 | 937.62 | 449.36 | 473.61 | 209.96 | 228.22 | 246.16 | 93.09 | 104.77 | 107.31 | 109.25 | |
| Total non-current assets | 17.53 | 13.62 | 18.14 | 17.15 | 16.93 | 12.12 | 9.57 | 9.41 | 7.87 | 8.41 | 6.41 | 1.21 | 1.20 | 4.76 | 3.64 | -107.31 | 1.91 | |
| Total assets | 1,508.12 | 1,583.92 | 832.16 | 816.44 | 866.55 | 903.33 | 933.22 | 947.03 | 457.23 | 482.02 | 216.37 | 229.43 | 247.35 | 97.85 | 108.41 | 111.16 | ||
| Total current liabilities | 56.98 | 63.29 | 57.53 | 39.03 | 36.49 | 36.02 | 33.43 | 22.66 | 23.59 | 24.74 | 20.09 | 15.01 | 11.00 | 13.01 | 12.23 | 8.66 | ||
| Total non-current liabilities | 4.05 | 4.26 | 4.61 | 5.33 | 5.42 | 2.47 | 2.98 | 3.34 | 3.82 | 4.31 | 3.32 | 0.00 | 5.11 | 199.98 | 200.09 | 167.23 | ||
| Total liabilities | 61.03 | 67.54 | 62.14 | 44.36 | 41.91 | 38.49 | 36.42 | 26.00 | 27.41 | 29.05 | 23.41 | 15.01 | 11.00 | 212.99 | 212.32 | 175.89 | ||
| Total stockholders' equity | 1,447.09 | 1,516.38 | 770.02 | 772.08 | 824.64 | 864.84 | 896.80 | 921.03 | 429.82 | 452.97 | 192.96 | 214.41 | 236.35 | -115.14 | -103.91 | 102.23 | -64.74 | |
| Common shares outstanding | 72 | 59 | 58 | 58 | 57 | 57 | 57 | 49 | 47 | 46 | 38 | 38 | 37 | 37 | 39 | 37 | 37 | 37 |